Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
The Fly
Bayer announces new drug application for gadoquatrane accepted for review by FDA
2d ago
Premium
The Fly
Bayer sees FY25 sales EUR 46B-EUR 48B on currency-adjusted basis
23d ago
Premium
The Fly
Bayer establishes additional provisions around EUR 1.2B for Roundup litigation
23d ago
Premium
The Fly
Bayer ‘making headway’ on improving profitability in agricultural business
23d ago
Premium
The Fly
Bayer reports Q2 core EPS EUR 1.23 vs. EUR 0.94 last year
23d ago
Premium
The Fly
Bayer affirms aim to ‘significantly’ contain litigation risk by end of 2026
23d ago
Premium
The Fly
Bayer says FDA extends review period for elinzanetant NDA
1M ago
Premium
The Fly
Avidity, Phathom mentioned as potential takeout targets at Needham
1M ago
BMY
NVO
Premium
The Fly
Bayer’s emodepside granted FDA orphan designation
1M ago
Premium
Company Announcements
Bayer AG Management Engages in Share Purchase to Boost Stakeholder Confidence
1M ago
Premium
The Fly
RedHill initiates recruitment for expanded Phase 2 opaganib/darolutamide study
2M ago
RDHL
Premium
The Fly
BridgeBio raises $300M via parital capped monetization of European royalty
2M ago
BBIO
Premium
The Fly
Orion says Bayer reports CHMP recommends third indication for darolutamide
2M ago
Premium
The Fly
Bayer upgraded to Buy from Hold at HSBC
3M ago
Premium
The Fly
Bayer upgraded to Buy from Hold at Kepler Cheuvreux
3M ago
Premium
The Fly
Bayer upgraded to Buy from Neutral at Goldman Sachs
3M ago
Premium
The Fly
Bayer price target raised to EUR 28 from EUR 26 at Morgan Stanley
3M ago
Premium
The Fly
Bayer says FDA accepts NDA under priority review for sevabertinib
3M ago
Premium
The Fly
Bayer price target raised to EUR 25 from EUR 22 at Barclays
3M ago
Premium
The Fly
Trump Trade: Trump considers 50% tariff on EU, 25% on iPhones
3M ago
F
K
Premium
The Fly
OTC Markets Group welcomes Bayer to OTCQX
3M ago
Premium
The Fly
Trump admin report implies companies are worsening health of children, FT says
3M ago
K
CAG
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
